Skip to main content

Advocacy News

News and views on the regulatory, legislative, and political issues impacting ophthalmology in Washington, D.C., and around the United States

Image
New Hampshire State House
Member exclusive - Locked
Featured News

For the third straight year, New Hampshire ophthalmologists have successfully defended safe eye surgery.

Read the Story
Filters
Advocacy Issues
Member exclusive - Locked
November 20, 2024
New Add-On Code for Post-Operative Care Finalized in Medicare 2025 Rule
Learn about new add on code G0559 and how it can be used.
Member exclusive - Locked
November 18, 2024
K. David Epley, MD: Without a Seat at the Table, Our Voice Goes Unheard
A Surgical Scope Fund Committee member and former OPHTHPAC committee member explains how your contributions drive the Academy’s advocacy efforts.
Image
A closeup photo of a doctor's hands wearing blue latex gloves as he pulls medicine from a small bottle with a syringe
Member exclusive - Locked
November 13, 2024
Ophthalmology Calls for Step Therapy Pause for Repackaged Avastin During Supply Chain Disruption

CMS signaled a willingness to review the request in its Nov. 12 meeting with the Academy and the American Society of Retina Specialists.

Image
A closeup of a medicine bottle that reads "Bevacizumab 100mg / 4ml"
Member exclusive - Locked
November 13, 2024
Aetna Offers Step Therapy Bypass to Ophthalmologists Unable to Source Compounded Avastin

Practices can note access issues in precertification requests to be granted an exemption from step therapy requirements. 

Member exclusive - Locked
October 30, 2024
Academy Urges Insurers to Suspend Step Therapy Due to Potential Avastin Supply Issues

The Academy urged large commercial insurers and Medicare Advantage plans to suspend anti-VEGF step therapy requirements in response to Pine Pharmaceuticals discontinuation of repackaged Avastin (bevacizumab).

Member exclusive - Locked
October 14, 2024
Data Validation Audits Begin for 2023 MIPS Participants
MIPS participants who are randomly selected for the audit will receive email notifications between October 2024 and April 2025.
Image
A closeup photo of a doctor's hands wearing blue latex gloves as he pulls medicine from a small bottle with a syringe
Member exclusive - Locked
October 14, 2024
Pine Pharmaceuticals Discontinues Avastin and Other Ophthalmic Product Manufacturing

The Academy is engaging with alternative suppliers and pushing CMS to intervene on Medicare Advantage plan step therapy requirements for Avastin. 

Member exclusive - Locked
October 2, 2024
Final MIGS Medicare Coverage Improves on 2023 Policy Proposals
Persistent advocacy from our ophthalmology coalition has led to improvements in final MIGS Medicare coverage policies.
Image
House Representative and ophthalmologist Mariannette Miller-Meeks speaks on the House floor
Member exclusive - Locked
October 2, 2024
Ophthalmologist Lawmaker Needs Your Support More than Ever

Ophthalmology’s top champion in the U.S. House of Representatives, Rep. Mariannette Miller-Meeks, MD, R-Iowa, urgently needs your support or she risks losing her reelection in what will prove to be a very close race.

Member exclusive - Locked
July 17, 2024
Ophthalmology Pushes for MIGS, Cataract, and Botulinum Toxin Medicare Coverage
The Academy submitted comments to regional Medicare contractors last week defending coverage of MIGS, cataract surgery, and botulinum toxin injections.